| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 946 | 3.484 | 5.519 | 8.764 | 8.678 | 10.695 | 4.376 | 2.985 |
| Total Income - EUR | 0 | 0 | 946 | 3.484 | 5.519 | 8.764 | 8.678 | 10.695 | 4.376 | 2.985 |
| Total Expenses - EUR | 2.269 | 529 | 1.453 | 1.229 | 4.076 | 1.204 | 1.506 | 1.542 | 2.694 | 2.530 |
| Gross Profit/Loss - EUR | -2.269 | -529 | -508 | 2.255 | 1.443 | 7.559 | 7.173 | 9.152 | 1.682 | 455 |
| Net Profit/Loss - EUR | -2.269 | -529 | -536 | 2.150 | 1.277 | 7.329 | 6.943 | 8.895 | 1.445 | 388 |
| Employees | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Dalcer Aldamed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 641 | 461 | 281 |
| Current Assets | 0 | 0 | 10 | 2.233 | 3.157 | 6.962 | 13.805 | 22.027 | 23.628 | 24.146 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 0 | 341 | 781 | 7.839 | 17.625 | 19.017 | 18.721 |
| Cash | 0 | 0 | 10 | 2.233 | 2.815 | 6.181 | 5.965 | 4.402 | 4.610 | 5.426 |
| Shareholders Funds | -3.004 | -3.502 | -3.979 | -1.756 | -444 | 6.893 | 13.684 | 22.622 | 23.998 | 24.252 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 3.004 | 3.502 | 3.989 | 3.989 | 3.601 | 69 | 121 | 46 | 90 | 175 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8690 - 8690" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Dalcer Aldamed Srl